Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.
Robert Hsu(University of Southern California), Jorge J. Nieva(University of Southern California), J. Nicholas Bodor(Fox Chase Cancer Center), W. Michael Korn(Itasca Community College), Stephen V. Liu(Georgetown University), Hina Khan(Albert Einstein College of Medicine), Sonam Puri(University of Utah), Misako Nagasaka(University of California, Irvine), Yasmine Baca(Caris Life Sciences (United States)), Joanne Xiu(Caris Life Sciences (United States)), Rong‐Fu Wang(Houston Methodist), Chul Kim(Georgetown University), Hirva Mamdani(Wayne State University)
Cited by 0
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
|Frontiers in Immunology|2022|880
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
|Journal of Clinical Oncology|2021|818
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
|Journal of Neuroinflammation|2019|746
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
|Journal of Clinical Oncology|2017|653